Pradžia › Alzheimerio liga › Texas
Alzheimerio liga klinikiniai tyrimai Texas
40 tyrimai dėl Alzheimerio liga ieško dalyvių vietose Texas.
Miestai Texas
- Houston12 tyrimai
- Dallas12 tyrimai
- San Antonio10 tyrimai
- Austin10 tyrimai
- Cypress7 tyrimai
- Beaumont6 tyrimai
- Round Rock4 tyrimai
- El Paso4 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- Baylor College of Medicine, Houston
Renkami dalyviai
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07667478A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Austin
- Clinical Site, McKinney
- Clinical Site, Sugarland
Renkami dalyviai2 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Horizon Clinical Research Group, Cypress
- University of Texas Health Science Center at San Antonio, San Antonio
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Epic Medical Research, LLC - Carrolton, Carrollton
- Local Institution - 2605, Cypress
- Local Institution - 1643, El Paso
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Mt. Olympus Medical Research, Llc - Katy, Katy
Renkami dalyviai4 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07633470Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
Renkami dalyviai1/2 fazė
Amžius nuo 50 iki 86 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07651319A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Gadolin Research, Beaumont
- Kerwin Medical Center, Dallas
- Houston Methodist Hospital, Houston
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 55 iki 85 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07589595A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
- Kerwin Medical Center- Site Number : 8400006, Dallas
Renkami dalyviai2 fazė
Amžius nuo 55 iki 85 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07688213A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Senior Adults Specialty Research, Austin
- Local Institution - 1260, Dallas
- Epic Medical Research LLC - DeSoto, DeSoto
- ir dar 5
Renkami dalyviai3 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Kerwin Research Center, LLC - Oak Cliff, Dallas
- Kerwin Research Center, LLC in Texas, Dallas
Renkami dalyviai2 fazė
Amžius nuo 55 iki 80 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Gadolin Research, LLC, Beaumont
- South Texas Research Institute - Brownsville, Brownsville
- Kerwin Medical Center, Dallas
- ir dar 6
Renkami dalyviai3 fazė
Amžius nuo 50 iki 90 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07177352A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Kerwin Medical Center /ID# 277788, Dallas
Renkami dalyviai1/2 fazė
Amžius nuo 50 iki 90 · Visoms lytims · Atnaujinta 2026-09-18 · NCT07599670A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Local Institution - 0081, Dallas
- Central Texas Neurology Consultants, PA, Round Rock
Renkami dalyviai3 fazė
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Epic Medical Research, LLC - Carrolton, Carrollton
- Horizon Clinical Research Center - Houston, Cypress
- Epic Medical Research, LLC - Mesquite, Mesquite
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Advanced Neurology Epilepsy and Sleep Center, El Paso
Renkami dalyviai3 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07011732Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
- Health Discovery Building, Austin
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-09-02 · NCT05907343Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Pinnacle Clinical Research, Austin
- Horizon Clinical Research Center - Houston, Cypress
- ANESC Research, El Paso
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Gadolin Research ( Site 1032), Beaumont
- Horizon Clinical Research Center - Houston ( Site 1026), Cypress
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-08-26 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Gadolin Research, Beaumont
Renkami dalyviai3 fazė
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-08-20 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- National Neuromuscular Research Institute, Austin
- University of Texas Southwestern, Dallas
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-04 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
Renkami dalyviai2/3 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Kerwin Research and Memory Center, Dallas
Renkami dalyviai2/3 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-27 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Senior Adults Specialty Research, Austin
- Gadolin Research, Beaumont
- The University of Texas Health Science Center at Houston, Houston
- ir dar 1
Renkami dalyviai3 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT07602582Epidemiology and Biomarker Study in Alzheimer's Disease
- Care Access - Houston, Houston
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius nuo 55 iki 75 · Visoms lytims · Atnaujinta 2026-07-07 · NCT07142954A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- University of Texas Health Science Center at San Antonio, San Antonio
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-06-26 · NCT07094516Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
- University of Texas at Austin, Austin
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-06-10 · NCT05741853Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
- University of Texas at Austin, Austin
Renkami dalyviaiAnkstyvoji 1 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-10 · NCT06511752[18F]PI-2620 Phase 3 Histopathological Study
- Baylor Research Institute, Dallas
- Sante Clinical Research, Kerrville
- Be Well Clinical Studies, Round Rock
Renkami dalyviai3 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-05-22 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- University of Texas Health San Antonio, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 25 iki 55 · Visoms lytims · Atnaujinta 2026-05-18 · NCT04165109Late Onset Alzheimer's Disease
- University of Texas Southwestern, Dallas
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-05-18 · NCT05010603Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
- Michael E. DeBakey VA Medical Center, Houston
Renkami dalyviai
Amžius nuo 65 iki 85 · Visoms lytims · Atnaujinta 2026-05-07 · NCT06835283δ in Dementia Clinical Trials
- Univeristy of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio
Renkami dalyviai
Amžius nuo 65 iki 100 · Visoms lytims · Atnaujinta 2026-05-05 · NCT05592678Stem Cell Therapy for Early Alzheimer's Disease
- The University of Texas Health Science Center at Houston (UTHealth), Houston
Renkami dalyviai1/2 fazė
Amžius nuo 60 iki 80 · Visoms lytims · Atnaujinta 2026-04-20 · NCT06775964Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Gadolin Research LLC, Beaumont
- Re:Cognition Health, Houston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 60 iki 90 · Visoms lytims · Atnaujinta 2026-04-15 · NCT06584357Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
- Houston Methodist Research Institute, Houston
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2026-04-06 · NCT05582200Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
- University of Texas Health Science Center at San Antonio, San Antonio
Renkami dalyviai
Amžius nuo 60 iki 85 · Visoms lytims · Atnaujinta 2026-02-11 · NCT06801639Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Houston
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-02-02 · NCT07105709Paper-Based and Smartphone-Based Memory Supports
- UT Health Austin Comprehensive Memory Center, Austin
- Baylor Scott & White Healthcare, Temple
- Baylor University, Waco
Renkami dalyviai
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2024-07-09 · NCT06444841Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Caraday Healthcare, LLC, San Marcos
Renkami dalyviai
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2024-03-12 · NCT05820919Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- The University of Texas at Austin, Austin
Renkami dalyviai4 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2022-05-18 · NCT03082755Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.